118 related articles for article (PubMed ID: 9102418)
1. [Lung cancer: progress in diagnosis and treatment. I. Diagnosis and physiopathology: 4. Progress in the study of tumor markers].
Kuwabara M; Shibata N; Ariyoshi Y
Nihon Naika Gakkai Zasshi; 1997 Jan; 86(1):20-6. PubMed ID: 9102418
[No Abstract] [Full Text] [Related]
2. Alpha-fetoprotein as tumor marker in lung cancer diagnosis.
Coni F; Cunazza M; Cianci R; Baldi C; Libertucci D; Molinatti M; Pecchio F; Rapellino M
J Nucl Med Allied Sci; 1989; 33(3 Suppl):98-100. PubMed ID: 2480434
[TBL] [Abstract][Full Text] [Related]
3. [Telomerase activity as a novel marker of lung cancer].
Hiyama K; Ishioka S; Hiyama E; Yamakido M
Nihon Rinsho; 1998 May; 56(5):1253-7. PubMed ID: 9613133
[TBL] [Abstract][Full Text] [Related]
4. Detection of lung cancer by oral examination.
Xiong Z; Xiong G; Man Y; Wang L; Jing W
Med Hypotheses; 2010 Feb; 74(2):346-7. PubMed ID: 19758766
[TBL] [Abstract][Full Text] [Related]
5. [Tumor markers and genetic changes in lung cancer].
Dediu M
Pneumologia; 1999; 48(4):317-20. PubMed ID: 10856995
[No Abstract] [Full Text] [Related]
6. [Molecular biology in the diagnosis of lung cancer].
Haugen A
Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3283-5. PubMed ID: 16327855
[TBL] [Abstract][Full Text] [Related]
7. [Differential lung cancer diagnosis--progress or fiasco?].
Müller KM
Fortschr Med; 1990 Apr; 108(11):17-9. PubMed ID: 2162802
[No Abstract] [Full Text] [Related]
8. Diagnostic and prognostic importance of tumor markers in lung cancer.
Ulsperger E; Karrer K
Suppl J Med Oncol Tumor Pharmacother; 1988; 1():21-31. PubMed ID: 3074224
[No Abstract] [Full Text] [Related]
9. Comparison of ROC umbrella volumes with an application to the assessment of lung cancer diagnostic markers.
Alonzo TA; Nakas CT
Biom J; 2007 Aug; 49(5):654-64. PubMed ID: 17726716
[TBL] [Abstract][Full Text] [Related]
10. [A clinical study on neuron specific enolase (NSE) as a tumor marker in primary lung cancer].
Suzuki K; Reshad K; Takahashi Y; Morita H; Hirata T; Itoi K; Nakano Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Jun; 25(6):625-31. PubMed ID: 2824900
[No Abstract] [Full Text] [Related]
11. Biological markers in lung cancer: A clinician's perspective.
Tufman A; Huber RM
Cancer Biomark; 2010; 6(3-4):123-35. PubMed ID: 20660959
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment for metastatic pulmonary tumor].
Matsuzaki Y; Shimizu T; Onitsuka T
Nihon Rinsho; 2000 May; 58(5):1136-41. PubMed ID: 10824563
[TBL] [Abstract][Full Text] [Related]
13. Biological, molecular, and clinical markers for the diagnosis and typing of lung cancer.
Gazdar AF; Mulshine JL; Kramer BS
Immunol Ser; 1990; 53():453-68. PubMed ID: 1966068
[No Abstract] [Full Text] [Related]
14. [Lung cancer].
Haugen A
Tidsskr Nor Laegeforen; 1998 Jun; 118(15):2362-5. PubMed ID: 9691805
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer and its early detection using biomarker-based biosensors.
Arya SK; Bhansali S
Chem Rev; 2011 Nov; 111(11):6783-809. PubMed ID: 21774490
[No Abstract] [Full Text] [Related]
16. [Clinical presentation of lung cancer].
Eguchi K
Nihon Rinsho; 2002 May; 60 Suppl 5():141-4. PubMed ID: 12101643
[No Abstract] [Full Text] [Related]
17. [Combined diagnosis of primary lung cancer using immunological tests].
Bakhlaev IE; Oleínik EK; Ageenko AI; Erkhov VS; Trakhtenberg AK
Klin Med (Mosk); 1997; 75(8):45-8. PubMed ID: 9340439
[TBL] [Abstract][Full Text] [Related]
18. [Lung cancer: progress in diagnosis and treatment. I. Diagnosis and physiopathology: 3. Diagnosis related to bronchoscopy].
Kusunoki Y
Nihon Naika Gakkai Zasshi; 1997 Jan; 86(1):15-9. PubMed ID: 9102416
[No Abstract] [Full Text] [Related]
19. Lung cancer biomarkers - Where we are and what we need.
Stieber P; Holdenrieder S
Cancer Biomark; 2010; 6(3-4):221-4. PubMed ID: 20660967
[No Abstract] [Full Text] [Related]
20. [Evaluation of usefulness of tumor markers in the management of lung cancer].
Ariyoshi Y
Rinsho Byori; 1989 Feb; 37(2):113-7. PubMed ID: 2733177
[No Abstract] [Full Text] [Related]
[Next] [New Search]
